globulin in both adults' and children,2 and IgA is more important in the upper airway. IgG is an efficient fixer of complement, so there is the potential in the lower respiratory tract for IgG hypersensitivity mechanisms to occur if there is immune dysregulation. The most important cause of progressive pulmonary disease in cystic fibrosis is likely to be chronic infection with Pseudomonas aeruginosa.3 Two studies, however, have shown that children with cystic fibrosis and low concentrations of serum IgG had better lung function and general health than age matched children with cystic fibrosis and normal IgG concentrations.i5 Overall, patients with cystic fibrosis have higher serum IgG and IgM concentrations than control subjects.6 It has also been shown that high titres of precipitating antibodies to P aeruginosa in patients with cystic fibrosis may be harmful rather than protective.7-8
Circulating immune complexes are common in cystic fibrosis, and are associated with acute respiratory exacerbations and deteriorating pulmonary function.9 These features suggest that hypersensitivity mechanisms and increased inflammatory activity may participate in the pulmonary damage. Indeed the results of a trial of prednisolone given on alternate days to patients with cystic fibrosis suggested that there was an appreciable delay in deterioration of lung function tests and fewer hospital admissions in the group treated with prednisolone.
The frequency with which Aspergillus precipitins are detected in patients with cystic fibrosis varies from 30% to 60%,1112 and their number often parallels the severity of pulmonary disease.13 A fumigatus is a ubiquitous fungus, and all lungs are constantly exposed to it. Allergic aspergillosis has been reported in up to 11% of patients with cystic fibrosis, 4 but is rare in normal subjects. This suggests that patients with cystic fibrosis have an abnormal response to Aspergillus, and that there may be important abnormalities in mucosal regulation and defence in patients with cystic fibrosis. Unfortunately precipitation in gels is an insensitive, albeit specific, method for the detection of circulating Aspergillus antibody. In addition, it is qualitative, not quantitative.
Our aim was to characterise more fully the response to Aspergillus in patients with cystic fibrosis, and to relate the findings to their general health and pulmonary function. An 
